05 Mar 2015

BritLofex (Lofexidine hydrochloride) - United Kingdom

ATC: N07BC
NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
DRUGS USED IN ADDICTIVE DISORDERS
DRUGS USED IN OPIOID DEPENDENCE
BritLofex

Generic Matches for Lofexidine hydrochloride (1)
BritLofex Tablets 0.2mg

Last Updated on 05 Mar 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

BritLofex Indication

To relieve symptoms in patients undergoing opioid detoxification.

 

BritLofex Generic Name

Lofexidine hydrochloride

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - BritLofex Tablets 0.2mg (external site)

Related Learning Zones

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

BritLofex Marketing Information

BritLofex Generic Name
Lofexidine hydrochloride
Marketing Company
Britannia Pharmaceuticals Limited
Drug Type
POM
Date of Issue, Marketing Authority 01/10/1990

Related Drugs - Psychiatry/Mental Health

Back to top